Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension-Reference-Cited by-同舟云学术

Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension

Published:1999-11 Issue:5 Volume:160 Page:1500-1506
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

SCHERMULY RALPH THEO,GHOFRANI HOSSEIN ARDESCHIR,ENKE BEATE,WEISSMANN NORBERT,GRIMMINGER FRIEDRICH,SEEGER WERNER,SCHUDT CHRISTIAN,WALMRATH DIETER

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference35 articles.

1. Survival in Patients with Primary Pulmonary Hypertension

2. An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension

3. Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary Hypertension

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled Prostacyclin/Milrinone Therapy in Right Ventricular Failure: Implications for Noninvasive Mechanical Ventilation;Noninvasive Ventilation. The Essentials;2023

2. Effect of phosphodiesterase (1B, 2A, 9A and 10A) inhibitors on central nervous system cyclic nucleotide levels in rats and mice;Neurochemistry International;2019-10

3. Intravenous epoprostenol improves oxygenation index in patients with persistent pulmonary hypertension of the newborn refractory to nitric oxide;Journal of Perinatology;2018-07-25

4. Inhaled Vasodilators in Right Heart Failure;Right Heart Pathology;2018

5. Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension;Nanomedicine: Nanotechnology, Biology and Medicine;2016-01